ArticleFrontiers in plant science2026
Virus-mediated, heritable gene editing in groundcherry (
Article in Frontiers in plant science, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Virus-induced gene editing (VIGE) provides a powerful alternative to conventional plant genome engineering by enabling in planta delivery of genome-editing reagents without repeated use of tissue culture. Here, we establish Tobacco rattle virus (TRV)-mediated VIGE as an efficient system for somatic and heritable genome editing in groundcherry ( Methods: Using Cas9-expressing plants, we targeted the visual marker gene Results: Targeting of PDS resulted in somatic editing frequencies of 80-95% and consistent recovery of heritable edits, with all infected plants (n = 5) producing edited progeny, including fully albino seedlings carrying frameshift mutations in all alleles. The primary Cas9-expressing line was unexpectedly tetraploid, likely due to genome duplication during tissue culture. Despite this, VIGE efficiently generated mono-, bi-, tri-, and tetra-allelic mutations, demonstrating robust editing across four alleles simultaneously. Targeting of Conclusion: These results demonstrate that VIGE enables rapid, efficient, and heritable genome editing in groundcherry, even in a tetraploid context, highlighting its potential to accelerate genetic improvement and de novo domestication of underutilized crops.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.